Showing results (71-80 of 10,941) with videos related to
Sort By:
Pageof 1,095
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 30, 2016
Increased vascular eNOS and cystathionine-γ-lyase protein after 6 weeks oral administration of 3, 5, 7, 3', 4'-pentamethoxyflavone to middle-aged male ratsSomruedee Yorsin, Kanyanatt Kanokwiroon, Nisaudah Radenahmad, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 29, 2015
Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure modelsHakimeh Gavzan, Mohammad Sayyah, Soroush Sardari, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1981
Neurochemical and behavioural profiles of five dopamine analoguesC Sumners, D Dijkstra, J B de Vries, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1981
Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788P Polc, J P Laurent, R Scherschlicht, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 10, 2025
Deubiquitinase USP28 promotes the malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1Wu Wen, Zhenhua Zhou, Chao Chen, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 10, 2025
Population pharmacokinetics of levetiracetam in Chinese adult epilepsy patients with varying renal function: exposure simulation and individualized dosing adjustmentsRongrong Wang, Ze Li, Shu Li, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2025
Enhanced anticancer efficacy of aluminum-curcumin complex compared to curcumin in colorectal cancer cellsNarges Jabbari, Abdolreza SabokrouhNaunyn-Schmiedeberg'S Archives of Pharmacology|February 4, 2025
Metformin alleviates doxorubicin-induced hepatic damage by modulating oxidative stress: a molecular, biochemical, and histopathological approach in a rat modelShabnam Lal-Shahsavar, Naime Majidi Zolbanin, Abbas Jafari, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2025
Pharmacokinetic comparison of a fixed-dose combination of telmisartan/rosuvastatin/ezetimibe/amlodipine 80/20/10/5 mg and a loose-dose combination of ezetimibe/rosuvastatin 10/20 mg and telmisartan/amlodipine 80/5 mg in healthy male subjectsSooyoun Lee, Hyun Chul Kim, Kyung Tae Kim, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 12, 2025
Inhibitory effects of cornuside on human liver cytochrome P450 enzymesYanmo Yang, Ke Zhang, Mi ZhouPageof 1,095